Document:

Form of Non-Qualified Stock Option Award Agreement

 Exhibit 10.4 

 
 

 
 AMARIN CORPORATION plc 2011 STOCK INCENTIVE PLAN 

AWARD AGREEMENT 
 This
AWARD AGREEMENT (the “Agreement”) is entered into and made effective as of [                    ], 20    
between Amarin Corporation plc (the “Company”), and [                    ], (“Optionee”). Capitalized terms used
and not defined herein shall have the meanings set forth in the Amarin Corporation plc 2011 Stock Incentive Plan (the “Plan”). 
  

	1.	Number of Non-Qualified Stock Options (“Options”):
[                    ] 

  

					
	2.	 	Per Share Purchase Price: $[                   
]	 	(provided that such Per Share Purchase Price shall not be less than the par value of the Share at any time, currently £0.50)

  

	3.	Grant Date: [                    ]

  

	4.	Date Options Become Exercisable (Vesting): 

  

					
	 Number of Ordinary Shares
	  	Exercise Dates	 
	
[                    ]
	  	 	[                    	] 
	
[                    ]
	  	 	[                    	] 
	
[                    ]
	  	 	[                    	] 
	
[                    ]
	  	 	[                    	] 

  

	5.	Expiration Date: [                    ]

  

	6.	Terms of this Award Agreement: In the event of a conflict between the provisions of this Award Agreement and the Plan, except in relation to paragraph 7 below,
the provisions of the Plan shall prevail. A copy of the Plan is provided herewith. 

  

	7.	Non-transferable: These Options shall not be transferable by the Optionee other than by will or the laws of descent and distribution, and the Options shall be
exercisable, during the Optionee’s lifetime, only by the Optionee. 

 By signing this Award Agreement, you
agree to all of the terms and conditions described herein and in the Plan. 
  

											
		 	AMARIN CORPORATION plc	 	OPTIONEE
						
		 	By:	 	  
	 		 	Signature:	 	  

		 	Name:	 		 		 	Name:	 	[                    ]
		 	Title:Form of Restricted Stock Unit Award Agreement

 Exhibit 10.5 

 
 

 
 AMARIN CORPORATION plc 2011 STOCK INCENTIVE PLAN 

RESTRICTED STOCK UNIT AWARD AGREEMENT 
 This AWARD AGREEMENT (the “Agreement”) is entered into and made effective as of
[                    ], 20    by and between Amarin Corporation plc (the “Company”), and
[                    ] (“Participant”). Capitalized terms used and not otherwise defined herein shall have the meanings ascribed to
such terms in the Amarin Corporation plc 2011 Stock Incentive Plan (the “Plan”), which is incorporated by this reference in its entirety. The Company hereby grants to the Participant an award (this “Award”) of
restricted stock units (“RSUs”) as set forth below. The Company intends that this Award shall not be considered to provide for the deferral of compensation under section 409A of the Code and that this Award Agreement shall be so
administered and construed. Further, the Company may modify this Award Agreement and this Award to the extent necessary to fulfill this intent. 
  

	1.	Number of RSUs: [                    ]

  

	2.	Grant Date: [                    ] 

 

	3.	Expiration Date: [                    ]

  

	4.	Date Award Vests: 

[                    ] 

 

	5.	Vesting: Upon vesting of each RSU, the Participant shall be entitled to a payment equal to the Fair Market Value of one Share. The payment shall be paid to the
Participant in cash, or at the sole discretion of the Committee in Shares or a combination of cash or Shares, and any such Shares may be subject to restrictions concerning their transferability and/or forfeiture as the Committee may determine.

  

	6.	Termination: Notwithstanding anything in Section 8 of the Plan to the contrary, in the event of termination of the Participant’s Continuous
Status as an Employee or Consultant, any RSUs that have not vested will lapse immediately. 

  

	7.	Dilution Protection: The Plan contains detailed provisions for adjustments in the number and price of Shares for various corporate events, such as a change in
capitalization, or a corporate transaction. 

  

	8.	Withholding: The Company has the right to require payment for any withholding tax and social security contributions applicable to the vesting of the RSUs. Any
withholding in the form of Shares shall not exceed the required minimum withholding amount. 

  

	9.	Stockholder Rights: The Award itself does not confer the rights of the underlying Shares which are the subject of the Award. Shareholder rights derive only from
Share ownership. 

  

	10.	Contract: This Agreement and the Plan constitute the entire agreement between you and the Company with regard to the Award described herein, and may not be
modified or amended except in a writing duly executed by the Participant and an executive officer of the Company. 

  

	11.	Applicable Law: The Plan is not subject to the Employee Retirement Income Security Act of 1974, as amended, and is not qualified under Section 401(a) of the
Code. The laws of the State of New York govern the terms and conditions of the RSUs, the Plan, and any construction or interpretation of the same. 

 

 
  

	12.	Conflict: In the event of a conflict between the provisions of this Agreement and the Plan, the Plan shall control. A copy of the Plan is available from the
Company Secretary at the Company’s U.S. headquarters. 

  

	13.	Administration. The Committee will administer the Plan. The Board appoints the members of the Committee, who will remain members until removed by the Board.

 IN WITNESS WHEREOF, the Company and the Participant have executed this Agreement as of the day and year first
written above. 
  

											
		 	AMARIN CORPORATION plc	 	PARTICIPANT
						
		 	By:	 	  
	 		 	Signature	 	  

						
		 	Name:	 		 		 		 	
		 	Title:Amendment to API Commercial Supply Agreement

 Exhibit 10.51 
 CONFIDENTIAL 
 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE
OMITTED AND REPLACED WITH “[***]”. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT UNDER RULE 24b-2 OF
THE SECURITIES EXCHANGE ACT OF 1934. 
  
  

AMENDMENT TO API SUPPLY AGREEMENT 
 This AMENDMENT TO API SUPPLY AGREEMENT (the “Amendment”) is made as of this
19th day of October, 2011 (the “Amendment Effective
Date”), by and between Amarin Pharmaceuticals Ireland Ltd., a corporation organized under the laws of Ireland and having its principal office at First Floor, Block 3, The Oval, Shelbourne Road, Ballsbridge, Dublin 4, Ireland
(“Amarin”), and Equateq Limited, a company incorporated in England with registered number 5507387 and with its registered office at Lion House, Red Lion Street, London, WC1R 4GB but with its principal offices at Callanish, Isle of Lewis,
HS2 9ED (“Equateq”). 
 WHEREAS, the Parties entered into that certain API Supply Agreement as of May 25, 2011
(the “Agreement”); and 
 WHEREAS, the Parties wish to amend the Agreement as set forth herein. 

NOW THEREFORE, in consideration of the premises and mutual covenants herein below, and for other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows: 
 1. Capitalized terms used but not
defined herein shall have the meanings given to them in the Agreement. 
 2. Section 4.1(a) of the Agreement is deleted in
its entirety and replaced with the following: 
 (a) Amarin shall make a one time payment to Equateq of one
million dollars ($1,000,000) (the “Upfront Commitment Payment”) within five (5) Days of the Effective Date. Equateq shall notify Amarin when the financing to perform its obligations under this Agreement is in place, which notification
shall describe the financing terms with a reasonable level of detail and in the absence of notice of objection from Amarin within [***] of Equateq’s notification it shall be deemed accepted by Amarin. In the event Equateq has not, in
Amarin’s reasonable determination after good faith consultation with Equateq, raised sufficient capital to perform its obligations under this Agreement within [***] after the Effective Date, Amarin may give notice of that determination to
Equateq at any time prior to Equateq raising such sufficient capital, and Equateq shall refund the Upfront Commitment Payment to Amarin and whereupon this Agreement shall terminate automatically. 

 3. The Parties acknowledge that Amarin has paid the Upfront Commmittment Payment to Equateq.

 4. The following is hereby added to the end of Section 4.1(b): 

“Notwithstanding the foregoing, until Equateq has, in Amarin’s reasonable determination after good faith consultation with
Equateq, raised sufficient capital to perform its obligations under this Agreement, Amarin shall not be required to pay any Development Fees (the “Deferred Development Fees”); provided, however, that Amarin’s right to withhold payment
of Deferred Development Fees shall not relieve Equateq of its obligation to timely perform the Development Plan. Amarin shall have no obligation to pay the Deferred Development Fees at all if the Agreement is terminated pursuant to

Section 4.1(a). Amarin shall pay the Deferred Development Fees incurred in accordance with this Section 4.1(b) within [***] after Equateq has, in Amarin’s reasonable determination after good faith consultation
with Equateq, raised sufficient capital to perform its obligations under this Agreement prior to termination.” 
 5. The
following is hereby added to the end of Section 4.1(c) of the Agreement: 
 Nothwithstanding anything in this Agreement to
the contrary, in no event shall Amarin be required to pay any portion of the Third Party Materials Payment unless and until Equateq has in Amarin’s reasonable determination after good faith consultation with Equateq and in writing, raised
sufficient capital to perform its obligations under this Agreement. 
 6. This Amendment and any other future amendment of the
Agreement may be executed in two (2) or more counterparts, each of which shall be an original, but all of which together shall constitute one and the same instrument. To evidence the fact that it has executed this Amendment and any other future
amendment of the Agreement, a Party may send a copy of its executed counterpart to the other Parties by facsimile transmission or by email transmission in portable document format, or similar format. Signatures of the Parties transmitted by
facsimile or by email transmission in portable document format, or similar format, shall be deemed to be their original signatures for all purposes. 
 7. Except as expressly provided in this Amendment, all other provisions of the Agreement shall remain unmodified and in full force and effect. 

[signature page follows] 

  
 2 

 [Signature Page to Amendment to API Supply Agreement] 

IN WITNESS WHEREOF, the Parties have caused their duly authorized representative to execute this Amendment effective as of the Amendment
Effective Date. 
  

			
	AMARIN PHARMACEUTICALS IRELAND LTD.
		
	By:	 	 /s/ John F. Thero

	Name:	 	 John F. Thero

	Title:	 	 Director

	
	EQUATEQ LIMITED
		
	By:	 	 /s/ Adam Kelliher

	Name:	 	 Adam Kelliher

	Title:	 	 CEO

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00200-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00200-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00200-of-00352.parquet"}]]